{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T00:41:23Z","timestamp":1740184883569,"version":"3.37.3"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,2,3]],"date-time":"2022-02-03T00:00:00Z","timestamp":1643846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,2,3]],"date-time":"2022-02-03T00:00:00Z","timestamp":1643846400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","award":["NU17CE924869-03-00","NU17CE924992-01-00"],"award-info":[{"award-number":["NU17CE924869-03-00","NU17CE924992-01-00"]}],"id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R36DA046717","1T32 DA 022981"],"award-info":[{"award-number":["R36DA046717","1T32 DA 022981"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Primary Prevent"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1007\/s10935-022-00670-7","type":"journal-article","created":{"date-parts":[[2022,2,3]],"date-time":"2022-02-03T15:03:33Z","timestamp":1643900613000},"page":"337-357","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Leveraging the Prescription Drug Monitoring Program to Curb Opioid Prescribing in Arkansas"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7776-6157","authenticated-orcid":false,"given":"Corey J.","family":"Hayes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johnathan","family":"Goree","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jamie","family":"Turpin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haley","family":"Ortiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. Richard","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Srinivasa B.","family":"Gokarakonda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carrie","family":"Hyde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael A.","family":"Cucciare","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,2,3]]},"reference":[{"issue":"9","key":"670_CR1","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1001\/jama.2013.522","volume":"309","author":"DP Alford","year":"2013","unstructured":"Alford, D. P. (2013). Chronic back pain with possible prescription opioid misuse. JAMA, 309(9), 919. https:\/\/doi.org\/10.1001\/jama.2013.522","journal-title":"JAMA"},{"issue":"1","key":"670_CR2","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.annemergmed.2009.12.011","volume":"56","author":"DF Baehren","year":"2010","unstructured":"Baehren, D. F., Marco, C. A., Droz, D. E., Sinha, S., Callan, E. M., & Akpunonu, P. (2010). A statewide prescription monitoring program affects Emergency Department Prescribing Behaviors. Annals of Emergency Medicine, 56(1), 19\u201323. https:\/\/doi.org\/10.1016\/j.annemergmed.2009.12.011","journal-title":"Annals of Emergency Medicine"},{"issue":"6","key":"670_CR3","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1377\/hlthaff.2015.1673","volume":"35","author":"Y Bao","year":"2016","unstructured":"Bao, Y., Pan, Y., Taylor, A., Radakrishnan, S., Luo, F., Pincus, H. A., & Schackman, B. R. (2016). prescription drug monitoring programs are associated with sustained reductions in opioid prescribing by physicians. Health Affairs (Project Hope), 35(6), 1045\u20131051. https:\/\/doi.org\/10.1377\/hlthaff.2015.1673","journal-title":"Health Affairs (Project Hope)"},{"key":"670_CR4","unstructured":"Bonifas, T. (2014). Doctor shopping in virginia for illicit use of pain medication is on the decline. http:\/\/www.dhp.virginia.gov\/About\/News\/PMPRelease06092014.pdf"},{"key":"670_CR5","unstructured":"CDC WONDER. (2021). Retrieved September 1, 2017, from https:\/\/wonder.cdc.gov\/"},{"issue":"4","key":"670_CR6","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1111\/add.14068","volume":"113","author":"H-Y Chang","year":"2018","unstructured":"Chang, H.-Y., Murimi, I. B., Jones, C. M., & Alexander, G. C. (2018). Relationship between high-risk patients receiving prescription opioids and high-volume opioid prescribers. Addiction, 113(4), 677\u2013686. https:\/\/doi.org\/10.1111\/add.14068","journal-title":"Addiction"},{"key":"670_CR7","doi-asserted-by":"publisher","unstructured":"Chou, R., Fanciullo, G. J., Fine, P. G., Adler, J. A., Ballantyne, J. C., Davies, P., Donovan, M. I., Fishbain, D. A., Foley, K. M., Fudin, J., Gilson, A. M., Kelter, A., Mauskop, A., O\u2019Connor, P. G., Passik, S. D., Pasternak, G. W., Portenoy, R. K., Rich, B. A., Roberts, R. G., American Pain Society-American Academy of Pain Medicine Opioids Guidelines Panel. (2009). Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. The Journal of Pain\u202f: Official Journal of the American Pain Society, 10(2), 113\u2013130. https:\/\/doi.org\/10.1016\/j.jpain.2008.10.008","DOI":"10.1016\/j.jpain.2008.10.008"},{"issue":"2","key":"670_CR8","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1056\/NEJMc1204141","volume":"367","author":"TJ Cicero","year":"2012","unstructured":"Cicero, T. J., Ellis, M. S., & Surratt, H. L. (2012). Effect of abuse-deterrent formulation of OxyContin. The New England Journal of Medicine, 367(2), 187\u2013189. https:\/\/doi.org\/10.1056\/NEJMc1204141","journal-title":"The New England Journal of Medicine"},{"issue":"2","key":"670_CR9","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1056\/NEJMra1508490","volume":"374","author":"WM Compton","year":"2016","unstructured":"Compton, W. M., Jones, C. M., & Baldwin, G. T. (2016). Relationship between nonmedical prescription-opioid use and heroin use. New England Journal of Medicine, 374(2), 154\u2013163. https:\/\/doi.org\/10.1056\/NEJMra1508490","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"670_CR10","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.drugalcdep.2005.05.009","volume":"81","author":"WM Compton","year":"2006","unstructured":"Compton, W. M., & Volkow, N. D. (2006). Major increases in opioid analgesic abuse in the United States: Concerns and strategies. Drug and Alcohol Dependence, 81(2), 103\u2013107. https:\/\/doi.org\/10.1016\/j.drugalcdep.2005.05.009","journal-title":"Drug and Alcohol Dependence"},{"key":"670_CR11","doi-asserted-by":"publisher","unstructured":"Curtis, L. H., Stoddard, J., Radeva, J. I., Hutchison, S., Dans, P. E., Wright, A., Woosley, R. L., & Schulman, K. A. (2006). Geographic variation in the prescription of schedule II opioid analgesics among outpatients in the United States. Health Services Research, 41(3p1), 837\u2013855. https:\/\/doi.org\/10.1111\/j.1475-6773.2006.00511.x","DOI":"10.1111\/j.1475-6773.2006.00511.x"},{"issue":"3","key":"670_CR12","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1056\/NEJMsa1406143","volume":"372","author":"RC Dart","year":"2015","unstructured":"Dart, R. C., Surratt, H. L., Cicero, T. J., Parrino, M. W., Severtson, S. G., Bucher-Bartelson, B., & Green, J. L. (2015). Trends in opioid analgesic abuse and mortality in the United States. New England Journal of Medicine, 372(3), 241\u2013248. https:\/\/doi.org\/10.1056\/NEJMsa1406143","journal-title":"New England Journal of Medicine"},{"issue":"8","key":"670_CR13","doi-asserted-by":"publisher","DOI":"10.2196\/jmir.2810","volume":"15","author":"N Dasgupta","year":"2013","unstructured":"Dasgupta, N., Freifeld, C., Brownstein, J. S., Menone, C. M., Surratt, H. L., Poppish, L., Green, J. L., Lavonas, E. J., & Dart, R. C. (2013). Crowdsourcing black market prices for prescription opioids. Journal of Medical Internet Research, 15(8), e178. https:\/\/doi.org\/10.2196\/jmir.2810","journal-title":"Journal of Medical Internet Research"},{"key":"670_CR14","unstructured":"Data Resources | Drug Overdose | CDC Injury Center. (2020). Retrieved September 15, 2020, from https:\/\/www.cdc.gov\/drugoverdose\/resources\/data.html"},{"key":"670_CR15","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.genhosppsych.2017.04.011","volume":"47","author":"MI Demidenko","year":"2017","unstructured":"Demidenko, M. I., Dobscha, S. K., Morasco, B. J., Meath, T. H. A., Ilgen, M. A., & Lovejoy, T. I. (2017). Suicidal ideation and suicidal self-directed violence following clinician-initiated prescription opioid discontinuation among long-term opioid users. General Hospital Psychiatry, 47, 29\u201335. https:\/\/doi.org\/10.1016\/j.genhosppsych.2017.04.011","journal-title":"General Hospital Psychiatry"},{"key":"670_CR16","doi-asserted-by":"publisher","unstructured":"Dowell, D., Haegerich, T. M., & Chou, R. (2016a). CDC guideline for prescribing opioids for chronic pain \u2014 United States, 2016. MMWR. Recommendations and Reports, 65(1), 1\u201349. https:\/\/doi.org\/10.15585\/mmwr.rr6501e1er","DOI":"10.15585\/mmwr.rr6501e1er"},{"key":"670_CR17","doi-asserted-by":"publisher","unstructured":"Dowell, D., Haegerich, T. M., & Chou, R. (2016b). CDC guideline for prescribing opioids for chronic pain \u2014 United States, 2016. MMWR. Recommendations and Reports, 65(1), 1\u201349. https:\/\/doi.org\/10.15585\/mmwr.rr6501e1er","DOI":"10.15585\/mmwr.rr6501e1er"},{"issue":"8","key":"670_CR18","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1097\/00001888-200308000-00020","volume":"78","author":"PM Finucane","year":"2003","unstructured":"Finucane, P. M., Bourgeois-Law, G. A., Ineson, S. L., & Kaigas, T. M. (2003). A comparison of performance assessment programs for medical practitioners in Canada, Australia, New Zealand, and the United Kingdom. Academic Medicine, 78(8), 837\u2013843. https:\/\/doi.org\/10.1097\/00001888-200308000-00020","journal-title":"Academic Medicine"},{"key":"670_CR19","doi-asserted-by":"publisher","unstructured":"Foster, D. (2012). Commentary on Young & Havens (2012). A policymaker\u2019s perspective on drug use in Appalachia. Addiction, 107(3), 597\u2013598. https:\/\/doi.org\/10.1111\/j.1360-0443.2011.03678.x","DOI":"10.1111\/j.1360-0443.2011.03678.x"},{"issue":"3","key":"670_CR20","doi-asserted-by":"publisher","first-page":"181","DOI":"10.7326\/M17-0598","volume":"167","author":"JW Frank","year":"2017","unstructured":"Frank, J. W., Lovejoy, T. I., Becker, W. C., Morasco, B. J., Koenig, C. J., Hoffecker, L., Dischinger, H. R., Dobscha, S. K., & Krebs, E. E. (2017). Patient outcomes in dose reduction or discontinuation of long-term opioid therapy. Annals of Internal Medicine, 167(3), 181. https:\/\/doi.org\/10.7326\/M17-0598","journal-title":"Annals of Internal Medicine"},{"key":"670_CR21","unstructured":"Garner, C. (2019). OARRS initiative project driven by analytics. Retrieved February 14, 2019, from http:\/\/www.nascsa.org\/Conference2018\/presentations\/West.pdf"},{"issue":"10","key":"670_CR22","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1111\/j.1526-4637.2012.01452.x","volume":"13","author":"TC Green","year":"2012","unstructured":"Green, T. C., Mann, M. R., Bowman, S. E., Zaller, N., Soto, X., Gadea, J., Cordy, C., Kelly, P., & Friedmann, P. D. (2012). How does use of a prescription monitoring program change medical practice? Pain Medicine, 13(10), 1314\u20131323. https:\/\/doi.org\/10.1111\/j.1526-4637.2012.01452.x","journal-title":"Pain Medicine"},{"key":"670_CR23","doi-asserted-by":"publisher","unstructured":"Guy, G. P., Zhang, K., Bohm, M. K., Losby, J., Lewis, B., Young, R., Murphy, L. B., Dowell, D. (2017). Vital signs: Changes in opioid prescribing in the United States, 2006\u20132015. MMWR. Morbidity and Mortality Weekly Report, 66(26), 697\u2013704. https:\/\/doi.org\/10.15585\/mmwr.mm6626a4","DOI":"10.15585\/mmwr.mm6626a4"},{"key":"670_CR24","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.drugalcdep.2014.10.001","volume":"145","author":"TM Haegerich","year":"2014","unstructured":"Haegerich, T. M., Paulozzi, L. J., Manns, B. J., & Jones, C. M. (2014). What we know, and don\u2019t know, about the impact of state policy and systems-level interventions on prescription drug overdose. Drug and Alcohol Dependence, 145, 34\u201347. https:\/\/doi.org\/10.1016\/j.drugalcdep.2014.10.001","journal-title":"Drug and Alcohol Dependence"},{"issue":"1","key":"670_CR25","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1146\/annurev-publhealth-031914-122957","volume":"36","author":"A Kolodny","year":"2015","unstructured":"Kolodny, A., Courtwright, D. T., Hwang, C. S., Kreiner, P., Eadie, J. L., Clark, T. W., & Alexander, G. C. (2015). The prescription opioid and heroin crisis: A public health approach to an epidemic of addiction. Annual Review of Public Health, 36(1), 559\u2013574. https:\/\/doi.org\/10.1146\/annurev-publhealth-031914-122957","journal-title":"Annual Review of Public Health"},{"key":"670_CR26","doi-asserted-by":"publisher","first-page":"S31","DOI":"10.1016\/j.drugalcdep.2016.11.020","volume":"173","author":"PW Kreiner","year":"2017","unstructured":"Kreiner, P. W., Strickler, G. K., Undurraga, E. A., Torres, M. E., Nikitin, R. V., & Rogers, A. (2017). Validation of prescriber risk indicators obtained from prescription drug monitoring program data. Drug and Alcohol Dependence, 173, S31\u2013S38. https:\/\/doi.org\/10.1016\/j.drugalcdep.2016.11.020","journal-title":"Drug and Alcohol Dependence"},{"key":"670_CR27","unstructured":"Lipari, R., Van Horn, S., Hughes, A., & Williams, M. (2017). State and substate estimates of nonmedical use of prescription pain relievers\u2014results from the National Survey on Drug Use and Health. https:\/\/www.samhsa.gov\/data\/sites\/default\/files\/report_3187\/ShortReport-3187.html"},{"key":"670_CR28","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.jsat.2019.05.001","volume":"103","author":"TL Mark","year":"2019","unstructured":"Mark, T. L., & Parish, W. (2019). Opioid medication discontinuation and risk of adverse opioid-related health care events. Journal of Substance Abuse Treatment, 103, 58\u201363. https:\/\/doi.org\/10.1016\/j.jsat.2019.05.001","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"1","key":"670_CR29","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1056\/NEJMsa1514387","volume":"375","author":"E Meara","year":"2016","unstructured":"Meara, E., Horwitz, J. R., Powell, W., McClelland, L., Zhou, W., O\u2019Malley, A. J., & Morden, N. E. (2016). State legal restrictions and prescription-opioid use among disabled adults. The New England Journal of Medicine, 375(1), 44\u201353. https:\/\/doi.org\/10.1056\/NEJMsa1514387","journal-title":"The New England Journal of Medicine"},{"key":"670_CR30","unstructured":"Overdose Death Rates | National Institute on Drug Abuse (NIDA). (2021). Retrieved September 7, 2018, from https:\/\/www.drugabuse.gov\/related-topics\/trends-statistics\/overdose-death-rates"},{"issue":"7","key":"670_CR31","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1377\/hlthaff.2015.1496","volume":"35","author":"SW Patrick","year":"2016","unstructured":"Patrick, S. W., Fry, C. E., Jones, T. F., & Buntin, M. B. (2016). Implementation of prescription drug monitoring programs associated with reductions in opioid-related death rates. Health Affairs (Project Hope), 35(7), 1324\u20131332. https:\/\/doi.org\/10.1377\/hlthaff.2015.1496","journal-title":"Health Affairs (Project Hope)"},{"issue":"6","key":"670_CR32","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1155\/2008\/726804","volume":"13","author":"P Peng","year":"2008","unstructured":"Peng, P., Stinson, J. N., Choiniere, M., Dion, D., Intrater, H., LeFort, S., Lynch, M., Ong, M., Rashiq, S., Tkachuk, G., & Veillette, Y. (2008). Role of health care professionals in multidisciplinary pain treatment facilities in Canada. Pain Research and Management, 13(6), 484\u2013488. https:\/\/doi.org\/10.1155\/2008\/726804","journal-title":"Pain Research and Management"},{"issue":"1","key":"670_CR33","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1002\/pds.1681","volume":"18","author":"V Pradel","year":"2009","unstructured":"Pradel, V., Frauger, E., Thirion, X., Ronfle, E., Lapierre, V., Masut, A., Coudert, C., Blin, O., & Micallef, J. (2009). Impact of a prescription monitoring program on doctor-shopping for high dosage buprenorphine. Pharmacoepidemiology and Drug Safety, 18(1), 36\u201343. https:\/\/doi.org\/10.1002\/pds.1681","journal-title":"Pharmacoepidemiology and Drug Safety"},{"key":"670_CR34","first-page":"41","volume":"3","author":"RM Reisman","year":"2009","unstructured":"Reisman, R. M., Shenoy, P. J., Atherly, A. J., & Flowers, C. R. (2009). Prescription opioid usage and abuse relationships: an evaluation of state prescription drug monitoring program efficacy. Substance Abuse\u202f: Research and Treatment, 3, 41\u201351.","journal-title":"Substance Abuse : Research and Treatment"},{"issue":"5","key":"670_CR35","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s10935-015-0397-0","volume":"36","author":"C Ringwalt","year":"2015","unstructured":"Ringwalt, C., Schiro, S., Shanahan, M., Proescholdbell, S., Meder, H., Austin, A., & Sachdeva, N. (2015). The use of a prescription drug monitoring program to develop algorithms to identify providers with unusual prescribing practices for controlled substances. Journal of Primary Prevention, 36(5), 287\u2013299. https:\/\/doi.org\/10.1007\/s10935-015-0397-0","journal-title":"Journal of Primary Prevention"},{"issue":"6","key":"670_CR36","doi-asserted-by":"publisher","first-page":"772","DOI":"10.4088\/JCP.15M10386","volume":"77","author":"TD Saha","year":"2016","unstructured":"Saha, T. D., Kerridge, B. T., Goldstein, R. B., Chou, S. P., Zhang, H., Jung, J., Pickering, R. P., Ruan, W. J., Smith, S. M., Huang, B., Hasin, D. S., & Grant, B. F. (2016). Nonmedical prescription opioid use and DSM-5 nonmedical prescription opioid use disorder in the United States. The Journal of Clinical Psychiatry, 77(6), 772. https:\/\/doi.org\/10.4088\/JCP.15M10386","journal-title":"The Journal of Clinical Psychiatry"},{"key":"670_CR37","unstructured":"Scott, R., Armstrong, J. H., Poston, R., & Program Manager, M. (2013). Prescription drug monitoring program annual report. http:\/\/www.floridahealth.gov\/statistics-and-data\/e-forcse\/news-reports\/_documents\/2012-2013pdmp-annual-report.pdf"},{"issue":"8","key":"670_CR38","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1007\/s11606-017-4047-5","volume":"32","author":"K Seal","year":"2017","unstructured":"Seal, K., Becker, W., Tighe, J., Li, Y., & Rife, T. (2017). Managing chronic pain in primary care: It really does take a village. Journal of General Internal Medicine, 32(8), 931\u2013934. https:\/\/doi.org\/10.1007\/s11606-017-4047-5","journal-title":"Journal of General Internal Medicine"},{"key":"670_CR39","doi-asserted-by":"publisher","unstructured":"Shah, A., Hayes, C. J., & Martin, B. C. (2017). Characteristics of initial prescription episodes and likelihood of long-term opioid use\u2014United States, 2006\u20132015. MMWR. Morbidity and Mortality Weekly Report, 66(10), 265\u2013269. https:\/\/doi.org\/10.15585\/mmwr.mm6610a1","DOI":"10.15585\/mmwr.mm6610a1"},{"key":"670_CR40","unstructured":"State Prescription Drug Monitoring Programs. (2018). Retrieved October 20, 2018, from https:\/\/www.deadiversion.usdoj.gov\/faq\/rx_monitor.htm"},{"issue":"3","key":"670_CR41","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1002\/pds.3553","volume":"23","author":"HL Surratt","year":"2014","unstructured":"Surratt, H. L., O\u2019Grady, C., Kurtz, S. P., Stivers, Y., Cicero, T. J., Dart, R. C., & Chen, M. (2014). Reductions in prescription opioid diversion following recent legislative interventions in Florida. Pharmacoepidemiology and Drug Safety, 23(3), 314\u2013320. https:\/\/doi.org\/10.1002\/pds.3553","journal-title":"Pharmacoepidemiology and Drug Safety"},{"key":"670_CR42","unstructured":"The Physicians\u2019 Quandary with Opioids: Chronic Pain vs. Addiction. (2018). Retrieved September 4, 2018, from https:\/\/catalyst.nejm.org\/quandary-opioids-chronic-pain-addiction\/"},{"key":"670_CR43","unstructured":"U.S. State Prescribing Rates, 2016 | Drug Overdose | CDC Injury Center. (2016). Retrieved July 5, 2018, from https:\/\/www.cdc.gov\/drugoverdose\/maps\/rxstate2016.html"},{"key":"670_CR44","unstructured":"Viriginia Prescription Monitoring Program: 2010 Statistics. (2010)."},{"key":"670_CR45","doi-asserted-by":"publisher","unstructured":"Vivolo-Kantor, A. M., Seth, P., Gladden, R. M., Mattson, C. L., Baldwin, G. T., Kite-Powell, A., & Coletta, M. A. (2018). Vital Signs\u202f: Trends in Emergency Department Visits for Suspected Opioid Overdoses \u2014 United States, July 2016\u2013September 2017. MMWR. Morbidity and Mortality Weekly Report, 67(9), 279\u2013285. https:\/\/doi.org\/10.15585\/mmwr.mm6709e1","DOI":"10.15585\/mmwr.mm6709e1"},{"issue":"4","key":"670_CR46","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.annemergmed.2013.05.025","volume":"62","author":"SG Weiner","year":"2013","unstructured":"Weiner, S. G., Griggs, C. A., Mitchell, P. M., Langlois, B. K., Friedman, F. D., Moore, R. L., Lin, S. C., Nelson, K. P., & Feldman, J. A. (2013). Clinician impression versus prescription drug monitoring program criteria in the assessment of drug-seeking behavior in the Emergency Department. Annals of Emergency Medicine, 62(4), 281\u2013289. https:\/\/doi.org\/10.1016\/j.annemergmed.2013.05.025","journal-title":"Annals of Emergency Medicine"}],"container-title":["Journal of Prevention"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10935-022-00670-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10935-022-00670-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10935-022-00670-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,17]],"date-time":"2022-05-17T17:25:06Z","timestamp":1652808306000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10935-022-00670-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,3]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["670"],"URL":"https:\/\/doi.org\/10.1007\/s10935-022-00670-7","relation":{},"ISSN":["2731-5533","2731-5541"],"issn-type":[{"type":"print","value":"2731-5533"},{"type":"electronic","value":"2731-5541"}],"subject":[],"published":{"date-parts":[[2022,2,3]]},"assertion":[{"value":"13 January 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Goree receives consulting fees from Stratus Medical. All other authors declare they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This research study was conducted retrospectively from data obtained for clinical purposes. We consulted extensively with the IRB of the University of Arkansas for Medical Sciences who determined that our study did not need ethical approval. An IRB official waiver of ethical approval was granted from the IRB of the University of Arkansas for Medical Sciences.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}}]}}